mmp 9 (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
mmp 9
Mmp 9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 713 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mmp+2/MMP2+Polyclonal+antibody/10__1096_slash_fj__202602170r-137-42-44
Average 96 stars, based on 713 article reviews
Mmp 9, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 713 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mmp+2/MMP2+Polyclonal+antibody/10__1096_slash_fj__202602170r-137-42-44
Average 96 stars, based on 713 article reviews
mmp 9 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Incubation:Article Title: Hyodeoxycholic acid relieves neuropathic pain by activating farnesoid X receptor signaling Article Snippet: .. Tissue sections of each group were blocked with 1 % bovine serum albumin and 10 % donkey serum at room temperature for 1 h and then incubated at 4 °C overnight with primary antibodies for neuronal nuclear protein (NeuN) (1:500, Abcam, ab104224), ionized calcium-binding adapter molecule 1 (IBA-1) (1:500, Abcam, ab5076), glial fibrillary acidic protein (GFAP) (1:500, Millipore, MAB360), FXR (1:200, Proteintech, 25055–1-AP), Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. Article Title: Atractylodis Rhizoma-Atractylodis Macrocephala Rhizoma herbal pair restores intestinal mucosal barrier function in ulcerative colitis via activating Epac1/Rap1 pathway and inhibiting PI3K/AKT pathway Article Snippet: .. Membranes were incubated overnight at 4 °C with primary antibodies: MUC2 (Proteintech, 1∶1000, 27675-1-AP), zonula occludens-1 (ZO-1, Proteintech, 1∶1000, 21773-1-AP), occludin (Proteintech, 1∶1000, 27260-1-AP), claudin-1 (Proteintech, 1∶1000, 28674-1-AP), Activity Assay:Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG 2000 ( ML290001 , purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel ( ML182320 ) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG2000 (ML290001, purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel (ML182320) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and TUNEL Assay:Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG 2000 ( ML290001 , purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel ( ML182320 ) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG2000 (ML290001, purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel (ML182320) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Fluorescence:Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG 2000 ( ML290001 , purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel ( ML182320 ) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG2000 (ML290001, purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel (ML182320) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Microscopy:Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG 2000 ( ML290001 , purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel ( ML182320 ) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Article Title: An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer Article Snippet: DPPC (C159364505, purity>99%) and IR820 (C15811515, purity>80%) were purchased from Shanghai Macklin Biochemical Co., Ltd; MSPC (CG1057, purity>99%) was purchased from AVT (Shanghai) Pharmaceutical Tech Co., Ltd.; DSPE-PEG2000 (ML290001, purity>98%), PLGA-PEG-PLGA thermosensitive hydrogel (ML182320) were purchased from MeloPEG Co., Ltd; Bufalin (HS21305B1, purity>98%) was purchased from Baoji Chenguang Biological Technology Co., Ltd.; Apatinib (S524804, purity>98%) was purchased from Selleckchem Chemicals. .. ; Calcein/PI cell activity and cytotoxicity detection kit (101223240515), DiD fluorescent dye (C1039), TUNEL kit (C1088), DAPI (C1005) were purchased from Shanghai Beyotime Biotechnology Co., Ltd.; Apoptosis detection kit (AB-2869082) was purchased from Bedi Medical Device Co., Ltd.; Ki-67 (ab15580) was purchased from Abcam; Cleaved Caspase-3 (#9662) was purchased from CST; CD31 (11265-1-AP, VEGF (81323-2-RR) and Membrane:Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. Blocking Assay:Article Title: Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer. Article Snippet: Triple-negative breast cancer (TNBC) is highly malignant and lacks effective therapeutic drugs.. ATG4B, a critical cysteine protease in autophagy, regulates LC3B processing and recycling to promote autophagosome formation, and its activation represents a promising therapeutic strategy for cancer.. Based on structure-based drug design, this study conducted virtual screening of the SPECS compound library and optimized the structure through structure-activity relationship analysis, obtaining a novel ATG4B allosteric activator, 16a. other:Article Title: DNMT3b promotes proliferation and invasion by mediating HOPX DNA methylation in lung cancer Article Snippet: |
